NO831632L - Fremgangsmaate for fremstilling av substituerte imidazolyl-tiazol-derivater. - Google Patents
Fremgangsmaate for fremstilling av substituerte imidazolyl-tiazol-derivater.Info
- Publication number
- NO831632L NO831632L NO831632A NO831632A NO831632L NO 831632 L NO831632 L NO 831632L NO 831632 A NO831632 A NO 831632A NO 831632 A NO831632 A NO 831632A NO 831632 L NO831632 L NO 831632L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- substituted imidazolyl
- preparing substituted
- tiazol
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Lubricants (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/376,486 US4435396A (en) | 1982-05-10 | 1982-05-10 | Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO831632L true NO831632L (no) | 1983-11-11 |
| NO159932B NO159932B (no) | 1988-11-14 |
| NO159932C NO159932C (no) | 1989-02-22 |
Family
ID=23485203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO831632A NO159932C (no) | 1982-05-10 | 1983-05-09 | Fremgangsmaate for fremstilling av substituerte imidazolyl-tiazol-derivater. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4435396A (no) |
| EP (1) | EP0094191B1 (no) |
| JP (1) | JPS58206588A (no) |
| KR (1) | KR860000931B1 (no) |
| AT (1) | ATE33649T1 (no) |
| AU (2) | AU539244B2 (no) |
| CA (1) | CA1201120A (no) |
| CS (1) | CS252461B2 (no) |
| DD (1) | DD209828A5 (no) |
| DE (1) | DE3376322D1 (no) |
| DK (1) | DK163829B (no) |
| EG (1) | EG17029A (no) |
| ES (1) | ES522223A0 (no) |
| FI (1) | FI78481C (no) |
| GR (1) | GR79279B (no) |
| GT (1) | GT198302123A (no) |
| HU (2) | HU190899B (no) |
| IE (1) | IE55229B1 (no) |
| IL (1) | IL68630A (no) |
| NO (1) | NO159932C (no) |
| NZ (1) | NZ204158A (no) |
| PL (1) | PL141199B1 (no) |
| PT (1) | PT76662B (no) |
| SU (1) | SU1195907A3 (no) |
| YU (1) | YU42857B (no) |
| ZA (1) | ZA833286B (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554276A (en) * | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
| US4673677A (en) * | 1983-10-03 | 1987-06-16 | Pfizer Inc. | Method for treatment of gastrointestinal disorders |
| US4560690A (en) * | 1984-04-30 | 1985-12-24 | Pfizer Inc. | 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents |
| US4636498A (en) * | 1984-10-11 | 1987-01-13 | Pfizer Inc. | Formulation of antiinflammatory drugs |
| US4632993A (en) * | 1984-10-11 | 1986-12-30 | Pfizer Inc. | Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide |
| WO1986003203A1 (en) * | 1984-11-22 | 1986-06-05 | Yoshitomi Pharmaceutical Industries, Ltd. | Thienylthiazole derivatives |
| US4814341A (en) * | 1986-08-26 | 1989-03-21 | Reiter Lawrence A | 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents |
| EP0259085B1 (en) * | 1986-08-29 | 1991-08-21 | Pfizer Inc. | 2-guanidino-4-arylthiazoles for treatment of peptic ulcers |
| ES2054684T3 (es) * | 1986-10-29 | 1994-08-16 | Pfizer | Procedimientos para la preparacion de 2-(1-pentil-3-guanidino)-4-(2-metil-4-imidazolil) tiazol y el dihidrocloruro trihidratado cristalino del mismo. |
| WO1994028898A1 (en) * | 1993-06-15 | 1994-12-22 | Pfizer Inc. | H2-antagonists as immune stimulants in bacterial infections of cattle or swine |
| PE20110843A1 (es) | 2008-09-22 | 2011-12-08 | Cayman Chem Co | Derivados de 5-(1h-imidazol-5-il)-2-fenilpirimidina, como inhibidores de prostaglandina d sintasa hematopoyetica |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3519637A (en) | 1966-12-06 | 1970-07-07 | Hoffmann La Roche | 1-(4-thiazolylmethyl)nitroimidazole derivatives |
| DE2142585A1 (de) * | 1971-08-20 | 1973-02-22 | Schering Ag | 2-(5-nitro-2-thiazolyl)-benzimidazole |
| FR2284601A1 (fr) * | 1974-09-10 | 1976-04-09 | Inst Francais Du Petrole | Composes guanidino-heterocycliques alkyles, leur preparation et leur utilisation comme additifs pour carburants et lubrifiants |
| US4220654A (en) | 1979-06-04 | 1980-09-02 | Merck & Co., Inc. | Cyclic imidazole cyanoguanidines |
| US4374843A (en) * | 1980-10-14 | 1983-02-22 | Pfizer Inc. | 2-Guanidino-4-heteroarylthiazoles |
-
1982
- 1982-05-10 US US06/376,486 patent/US4435396A/en not_active Expired - Fee Related
-
1983
- 1983-05-03 SU SU833585699A patent/SU1195907A3/ru active
- 1983-05-04 DE DE8383302495T patent/DE3376322D1/de not_active Expired
- 1983-05-04 AT AT83302495T patent/ATE33649T1/de not_active IP Right Cessation
- 1983-05-04 GR GR71297A patent/GR79279B/el unknown
- 1983-05-04 EP EP83302495A patent/EP0094191B1/en not_active Expired
- 1983-05-05 CS CS833184A patent/CS252461B2/cs unknown
- 1983-05-05 YU YU996/83A patent/YU42857B/xx unknown
- 1983-05-06 HU HU831581A patent/HU190899B/hu not_active IP Right Cessation
- 1983-05-06 GT GT198302123A patent/GT198302123A/es unknown
- 1983-05-06 CA CA000427596A patent/CA1201120A/en not_active Expired
- 1983-05-06 HU HU862387A patent/HU196377B/hu not_active IP Right Cessation
- 1983-05-06 NZ NZ204158A patent/NZ204158A/en unknown
- 1983-05-06 PL PL1983241840A patent/PL141199B1/pl unknown
- 1983-05-07 EG EG275/83A patent/EG17029A/xx active
- 1983-05-09 FI FI831595A patent/FI78481C/fi not_active IP Right Cessation
- 1983-05-09 ES ES522223A patent/ES522223A0/es active Granted
- 1983-05-09 AU AU14363/83A patent/AU539244B2/en not_active Ceased
- 1983-05-09 ZA ZA833286A patent/ZA833286B/xx unknown
- 1983-05-09 PT PT76662A patent/PT76662B/pt unknown
- 1983-05-09 IE IE1061/83A patent/IE55229B1/en unknown
- 1983-05-09 NO NO831632A patent/NO159932C/no unknown
- 1983-05-09 KR KR1019830001962A patent/KR860000931B1/ko not_active IP Right Cessation
- 1983-05-09 DK DK205883A patent/DK163829B/da not_active Application Discontinuation
- 1983-05-09 DD DD83250744A patent/DD209828A5/de not_active IP Right Cessation
- 1983-05-09 IL IL68630A patent/IL68630A/xx unknown
- 1983-05-10 JP JP58081601A patent/JPS58206588A/ja active Pending
-
1984
- 1984-07-18 AU AU30815/84A patent/AU566755B2/en not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT73259A (en) | Process for preparing novel substituted pyrazinyl-1,2,4-oxadiazole-5-ones | |
| RO86425A (ro) | Procedeu pentru prepararea unor derivati ai n-fosfonometilglicinei | |
| RO86824A (ro) | Procedeu pentru prepararea unor cefalosporine | |
| NO159932C (no) | Fremgangsmaate for fremstilling av substituerte imidazolyl-tiazol-derivater. | |
| RO86319A (ro) | Procedeu pentru prepararea unor compusi de benzimidazol | |
| RO82467A (ro) | Procedeu pentru prepararea unor 4h-1,3-tiazin-4-one | |
| HUT36783A (en) | Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane | |
| IS2902A7 (is) | Aðferð til framleiðslu á 1,8-dihydroxy-10-acyl-9-anthrones, sérstaklega til meðferðar á psoriasis | |
| RO87709A (ro) | Procedeu pentru prepararea unor 1,1-alcandioli-carboxilati | |
| RO81927A (ro) | Procedeu pentru prepararea unor 5-dihidro0ifenoxi-tetrazolil | |
| NO813196L (no) | Fremgangsmaate for isomerisering av ergolinderivater. | |
| SE7704110L (sv) | Forfarande for framstellning och rening av sekretin | |
| OA06939A (fr) | Procédé de préparation de (trialcoxybenzyl)-1 pipérazines. | |
| SE8305386D0 (sv) | 15-cycloaliphatic derivatives of 13,14-didehydro-carboprostacyclins and process for their preparation | |
| FI880080A (fi) | Foerfarande foer framstaellning av 1,2,3,4-tetrahydro-5h-(1)bensopyrano-(3,4-c)pyridin-5-on. | |
| YU35263B (en) | Process for obtaining 6-(aminopheny)-2,3,5,6,-tetrahydroimidazo(2,1-b)thiazole | |
| RO81940A (ro) | PROCEDEU PENTRU PREPARAREA UNOR DERIVATI DE 6-HALO-OXO-7-(1-PIPEљAZINIL)-1,8-NAFTIRIDINA | |
| IT7830959A0 (it) | Metodo per la cura della psoriasi. |